Skip to main content

Table 2 PCR changes during treatment

From: Sofosbuvir and daclatasvir are safe and effective in treatment of recurrent hepatitis C virus in Egyptian patients underwent living donor liver transplantation

Item Frequency Percentage
PCR before
 Mean ± SD 366057.5 ± 376220.9
 Min–max 698–2000000
PCR 1 month after starting treatment
 Positive 0 0
 Negative 40 100
PCR after the end of treatment
 Positive 0 0
 Negative 40 100
PCR 3 months after the end of treatment
 Positive 0 0
 Negative 40 100
PCR 6 months after the end of treatment
 Positive 0 0
 Negative 40 100
PCR 9 months after the end of treatment
 Positive 0 0
 Negative 40 100